About the Product

Description


Nifenorm 10 Tablet containing Nifedipine is used for the management of hypertension and angina. It helps in lowering blood pressure and improving blood flow to the heart.

Nifedipine works as a calcium channel blocker by relaxing blood vessels, which reduces vascular resistance and improves circulation effectively.

The tablet is widely prescribed in cardiology and general practice for long-term management of cardiovascular conditions, leading to consistent demand and repeat usage.

With increasing prevalence of hypertension and heart-related disorders, this product offers strong business potential for retailers and distributors. Its long-term therapy requirement, regular prescription demand, and broad clinical acceptance make it a reliable product for consistent sales and growth in the cardiac segment.

Some patients may experience headache, dizziness, flushing, swelling of ankles, or palpitations. Rarely, severe hypotension or allergic reactions may occur and require medical attention.

Nifenorm 10 Tablet is indicated for the treatment of hypertension and angina pectoris. It helps control high blood pressure, reduce chest pain episodes, improve circulation, and decrease the risk of cardiovascular complications.

This medicine should be used under medical supervision. Patients should avoid sudden discontinuation without medical advice. Use cautiously in individuals with severe heart conditions or liver disorders. Regular blood pressure monitoring is recommended.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Nifenorm 10 Tablet in the PCD pharma franchise market?

Nifenorm 10 Tablet, containing Nifedipine 10mg, has strong demand in the cardiology and hypertension segment, making it a stable and high-volume product for medical distributors, wholesalers, and pharma franchise partners focusing on cardiovascular and chronic care portfolios.

Why should medical distributors include Nifenorm 10 Tablet in their product range?

Medical distributors and agencies can benefit from the consistent demand for calcium channel blockers used in hypertension, angina pectoris, and coronary artery disease management. Nifenorm 10 Tablet helps strengthen a comprehensive cardiology product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Nifenorm 10 Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Nifenorm 10 Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Nifenorm 10 Tablet distribution?

Wholesalers and medical agencies benefit from strong cardiac prescription demand, steady sales potential, reliable supply chain support, and professional assistance when partnering for Nifenorm 10 Tablet distribution.

How can I become a distributor or franchise partner for Nifenorm 10 Tablet?

Medical distributors, stockists, and wholesalers interested in Nifenorm 10 Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.